News | Interventional Radiology | June 19, 2019

Merit Medical Acquires Brightwater Medical Inc.

Acquisition brings Brightwater’s ConvertX system for treating severe obstructions of the ureter into Merit portfolio

Merit Medical Acquires Brightwater Medical Inc.

June 19, 2019 — Merit Medical Systems Inc. announced it has acquired Brightwater Medical Inc., based in Temecula, Calif. Brightwater Medical’s primary product, the ConvertX, is a single device used to replace a series of interventional radiology devices and procedures used to treat severe obstructions of the ureter.

The transaction consists of a $35 million upfront payment and potential earn-out payments of up to $15 million based on receipt of CE mark approval and achievement of future sales targets.

Brightwater Medical was founded by Robert Smouse, M.D., professor of radiology and surgery, University of Illinois College of Medicine. The ConvertX system is designed to be implanted once and converted from a nephroureteral catheter to a nephroureteral stent without requiring sedation or local anesthesia. Brightwater Medical recently received U.S. Food and Drug Administration (FDA) clearance for the ConvertX biliary stent system.

Merit Medical Chairman and CEO Fred P. Lampropoulos said the ConvertX system complements Merit’s Resolve drainage catheter portfolio and potentially drives pull-through of other Merit products such as InQwire guide wires, Advocate PTA balloons and other vascular products.

Over the next several months, Merit Medical intends to maintain Brightwater Medical’s production capabilities in Temecula while duplicating those capabilities in its catheter facility in Pearland, Texas, prior to transferring the ConvertX manufacturing operations to its Pearland facility.

For more information: www.merit.com

Related Content

The radiology industry is saddened to learn of the passing of another leader to COVID-19. Franklin Wilfred Sequeira, M.D., 72, of Cicero, Ind., passed away June 1, 2020. He was just short of celebrating his 40th year working with Radiology of Indiana as an interventional radiologist, never missing a day of work.

Franklin Wilfred Sequeira, M.D.

News | Coronavirus (COVID-19) | June 13, 2020
June 13, 2020 — The r
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility
News | Interventional Radiology | April 21, 2020
April 21, 2020 — Guerbet announced that it received U.S.
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...
Harel Gadot

Harel Gadot, Founder, Executive Chairman and President at XACT Robotics says their system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs.

News | Interventional Radiology | November 01, 2019
November 1, 2019 — XACT Robotics Ltd. announced that its firs
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Interventional Radiology | October 28, 2019
October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from im
Exact Imaging Receives FDA 510(k) Clearance for Sterile Transperineal Needle Guide
Technology | Ultrasound Imaging | October 24, 2019
Exact Imaging received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sterile Transperineal Needle...